All News

Found 2,840 articles

• EntreMed, Inc. To Acquire Miikana Therapeutics

  12/22/2005

• Roche And Trimeris, Inc. Release: New Data Show Two-Thirds Of Patients Achieve Undetectable Viral Load With FUZEON(R) And Investigational Protease Inhibitor

  12/20/2005

• Burrill & Company Release: Bio-Partnering Opportunities In China

  12/13/2005

• Isotechnika Inc. Announces Nine Month Safety Data From The Phase III Psoriasis Trial For ISA247

  12/8/2005

• Isotechnika Inc. Announces Additional Board Change

  12/6/2005

• Isotechnika Inc. Announces Board Change

  12/1/2005

• Trimeris, Inc. And Roche Release: FDA Issues Approvable Letter In Response To Application For Use Of FUZEON With Needle-Free Injection Device

  11/28/2005

• Response Biomedical Achieves Superior Performance Targets With Rapid Flu A Test Development

  11/28/2005

• Isotechnika Inc. Announces Change In Executive Management

  11/16/2005

• Emisphere Technologies, Inc. Provides 2005 Third Quarter Update

  11/10/2005

• Isotechnika Inc. To Host Analyst And Investor Meeting In New York City

  11/8/2005

• Isotechnika Inc.'s Presentation At Rodman & Renshaw Annual Healthcare Conference rescheduled

  11/7/2005

• Idenix Pharmaceuticals, Inc. Reports Third Quarter And Nine Month Financial Results

  11/4/2005

• Aspreva Pharmaceuticals Corporation Reports Third Quarter 2005 Results

  11/3/2005

• Response Biomedical Ranked Number 100 Fastest Growing Technology Company In North America On The 2005 Deloitte Technology Fast 500

  10/27/2005

• Roche Suspends Tamiflu Delivery In Canada, To Protect Supplies Elsewhere

  10/26/2005

• Clinical Study Results Build Case for Expanded Use of FUZEON(R)

  10/31/2004

• Genmab A/S's HuMax-CD4 Receives EU Orphan Drug Designation

  5/26/2004

• Versant Ventures Names Bradley J. Bolzon, Ph.D., Managing Director

  5/10/2004

• Isotechnika Inc. Announces Highlights and Financials for 2003

  3/28/2004